1. Home
  2. KOPN vs ASMB Comparison

KOPN vs ASMB Comparison

Compare KOPN & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kopin Corporation

KOPN

Kopin Corporation

HOLD

Current Price

$2.43

Market Cap

424.9M

Sector

Technology

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$32.62

Market Cap

553.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KOPN
ASMB
Founded
1984
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
424.9M
553.6M
IPO Year
1992
2010

Fundamental Metrics

Financial Performance
Metric
KOPN
ASMB
Price
$2.43
$32.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$4.25
$43.40
AVG Volume (30 Days)
2.8M
113.1K
Earning Date
11-12-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$45,602,295.00
$37,191,000.00
Revenue This Year
N/A
$42.01
Revenue Next Year
$43.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.02
31.30
52 Week Low
$0.71
$7.75
52 Week High
$4.16
$39.71

Technical Indicators

Market Signals
Indicator
KOPN
ASMB
Relative Strength Index (RSI) 44.09 40.44
Support Level $2.28 $35.05
Resistance Level $2.65 $36.92
Average True Range (ATR) 0.20 1.93
MACD 0.01 -0.62
Stochastic Oscillator 31.97 4.84

Price Performance

Historical Comparison
KOPN
ASMB

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: